Danni Gong
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Risk assessment and triage strategy of cervical cancer primary screening on HPV integration status: 5-year follow-up of a prospective cohort study.
Journal: Journal of the National Cancer Center
Published: June 12, 2024
Downregulation of VPS13C promotes cisplatin resistance in cervical cancer by upregulating GSTP1.
Journal: iScience
Published: October 07, 2022
Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway.
Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway.
Journal: Current cancer drug targets
Published: November 22, 2021
Somatic mutations and CRISPR/Cas9 library screening integrated analysis identifies cervical cancer drug-resistant pathways.
Journal: Clinical and translational medicine
Published: August 09, 2021
A Fifteen-Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 27, 2020
A systematic comparison of the anti-tumoural activity and toxicity of the three Adv-TKs.
Journal: PloS one
Published: November 24, 2013
Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer.
Journal: Cancer letters
Published: May 09, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026